List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 16 studies with search of: Open Studies | "Pyelonephritis"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Antibiotic Prophylaxis in Children With Pyelonephritis
Condition: Pyelonephritis
Interventions: Drug: Trimethoprim Sulfamethoxazole;   Drug: placebo
2 Unknown † Short-Term Antibiotic Therapy for Pyelonephritis in Childhood
Condition: Pyelonephritis
Intervention: Drug: ceftibuten
3 Recruiting Study for the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis
Conditions: Complicated Urinary Tract Infection;   Acute Pyelonephritis
Interventions: Drug: Levofloxacin;   Drug: ACHN-490 Injection
4 Not yet recruiting Efficacy and Safety Study of Short-term Antibiotic for Pyelonephritis in Women
Condition: Acute Uncomplicated Pyelonephritis
Intervention: Drug: Ceftriaxone
5 Recruiting Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
Conditions: Complicated Urinary Tract Infection;   Pyelonephritis
Interventions: Drug: CXA-201;   Drug: Levofloxacin
6 Recruiting Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
Conditions: Complicated Urinary Tract Infection;   Pyelonephritis
Interventions: Drug: CXA-201;   Drug: Levofloxacin
7 Recruiting GSK2251052 in Complicated Urinary Tract Infection
Conditions: Pyelonephritis;   Infections, Urinary Tract
Interventions: Drug: GSK2251052;   Drug: imipenem-cilastatin
8 Recruiting A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Condition: Complicated Urinary Tract Infections or Pyelonephritis
Interventions: Drug: doripenem;   Drug: doripenem placebo;   Drug: cefepime;   Drug: cefepime placebo
9 Not yet recruiting Study of the Safety, Tolerability, & Efficacy of MK-7655 + Imipenem/Cilastatin Vs Imipenem/Cilastatin Alone for the Treatment of Complicated Urinary Tract Infection (cUTI)(MK-7655-003)
Conditions: Complicated Urinary Tract Infections,;   Pyelonephritis
Interventions: Drug: MK-7655 250 mg with imipenem/cilastatin;   Drug: MK-7655 125 mg with imipenem/cilastatin;   Drug: imipenem/cilastatin with placebo;   Drug: Matching placebo to MK-7655
10 Recruiting Antibiotic Education for Children in an Emergency Care Unit
Conditions: Otorhinolaryngologic Diseases;   Respiratory Tract Infections;   Pyelonephritis;   Urinary Tract Infections
Intervention: Other: antibiotic education for children in an emergency care unit
11 Unknown † Contrast-Enhanced US of Spleen, Liver and Kidney
Conditions: Malaria;   Pyelonephritis;   Bacterial Infections
Intervention:
12 Not yet recruiting Bacterial and Host Genetic Risk Factors in Acute Pyelonephritis
Condition: Vesicoureteral Reflux
Intervention:
13 Unknown † Urinary Cytokine Levels as a Prognostic Marker for Kidney Scarring After Pyelonephritis
Condition: Kidney Scarring Post-Febrile UTI
Intervention:
14 Not yet recruiting Preventing Urinary Tract Infection Post-Surgery
Condition: Urinary Tract Infection
Intervention: Dietary Supplement: Cranberry powder
15 Unknown † Febrile Urinary Tract Infection Randomized Short Treatment Trial
Condition: Urinary Tract Infection
Intervention: Drug: short treatment (ciprofloxacin)
16 Recruiting Comparative Study of Coadministered Ceftaroline Fosamil and NXL104 vs. Intravenous Doripenem in Adult Subjects With Complicated Urinary Tract Infections
Condition: Urinary Tract Infections
Interventions: Drug: Ceftaroline fosamil and NXL104;   Drug: Doripenem;   Drug: Placebo

† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services